Ocala company reveals new COVID-19 drug for virus 'long haulers'

Ocala company reveals new COVID-19 drug for virus ‘long haulers’
Additional patients are in the process of being enrolled
Thomas Metevia, Digital Content Producer, Orlando
Tags: 
OCALA, Fla. – There’s a new COVID-19 drug in town and the company behind it hopes the treatment will help those suffering from post-COVID-19 infection chronic fatigue-like symptoms, who have been dubbed “long haulers.”
AIM ImmunoTech Inc. announced Wednesday that they officially provide the first dose to their first patient with the drug called Ampligen.
[TRENDING:
Ad
The company believes this to be the first clinical trial to treat a patient with COVID-19-induced chronic fatigue-like symptoms.

Related Keywords

Argentina ,Thomask Equels , ,Hunter Hopkins Center ,Immunotech Inc ,Hopkins Center ,Long Hauler ,Long Haulers ,Chronic Fatigue Syndrome ,அர்ஜெண்டினா ,வேட்டைக்காரன் ஹாப்கின்ஸ் மையம் ,ஹாப்கின்ஸ் மையம் ,நீண்டது ொலேற் ,நீண்டது ொஉலேர்ச் ,நாள்பட்ட சோர்வு நோய்க்குறி ,